Susquehanna International Group’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.04M | Sell |
206,401
-3,260
| -2% | -$16.4K | ﹤0.01% | 3190 |
|
|
2025
Q1 | $1.36M | Buy |
209,661
+31,523
| +18% | +$204K | ﹤0.01% | 2853 |
|
|
2024
Q4 | $1.31M | Buy |
178,138
+89,530
| +101% | +$657K | ﹤0.01% | 2602 |
|
|
2024
Q3 | $664K | Buy |
88,608
+22,716
| +34% | +$170K | ﹤0.01% | 3251 |
|
|
2024
Q2 | $586K | Sell |
65,892
-24,977
| -27% | -$222K | ﹤0.01% | 3283 |
|
|
2024
Q1 | $921K | Buy |
90,869
+18,341
| +25% | +$186K | ﹤0.01% | 2748 |
|
|
2023
Q4 | $730K | Sell |
72,528
-61,913
| -46% | -$623K | ﹤0.01% | 3316 |
|
|
2023
Q3 | $1.26M | Buy |
134,441
+82,678
| +160% | +$775K | ﹤0.01% | 2297 |
|
|
2023
Q2 | $1.27M | Sell |
51,763
-110,892
| -68% | -$2.72M | ﹤0.01% | 2422 |
|
|
2023
Q1 | $3.78M | Buy |
162,655
+130,249
| +402% | +$3.03M | ﹤0.01% | 1299 |
|
|
2022
Q4 | $820K | Sell |
32,406
-131,978
| -80% | -$3.34M | ﹤0.01% | 2556 |
|
|
2022
Q3 | $3.17M | Buy |
164,384
+109,865
| +202% | +$2.12M | ﹤0.01% | 1212 |
|
|
2022
Q2 | $1.39M | Sell |
54,519
-287,659
| -84% | -$7.33M | ﹤0.01% | 2086 |
|
|
2022
Q1 | $8.8M | Buy |
342,178
+151,194
| +79% | +$3.89M | ﹤0.01% | 799 |
|
|
2021
Q4 | $8M | Buy |
190,984
+33,129
| +21% | +$1.39M | ﹤0.01% | 894 |
|
|
2021
Q3 | $6.87M | Buy |
157,855
+59,170
| +60% | +$2.58M | ﹤0.01% | 978 |
|
|
2021
Q2 | $4.67M | Buy |
98,685
+84,516
| +596% | +$4M | ﹤0.01% | 1311 |
|
|
2021
Q1 | $726K | Sell |
14,169
-58,391
| -80% | -$2.99M | ﹤0.01% | 3396 |
|
|
2020
Q4 | $1.94M | Buy |
72,560
+19,878
| +38% | +$532K | ﹤0.01% | 1764 |
|
|
2020
Q3 | $1.81M | Sell |
52,682
-12,440
| -19% | -$427K | ﹤0.01% | 1543 |
|
|
2020
Q2 | $2.67M | Buy |
65,122
+53,605
| +465% | +$2.2M | ﹤0.01% | 1222 |
|
|
2020
Q1 | $395K | Buy |
+11,517
| New | +$395K | ﹤0.01% | 3139 |
|